Human keratinocytes restrict chikungunya virus replication at a post-fusion step

Virology

Volumn 476, Issue , 2015, Pages 1-10

  Bernard, Eric ^a   Hamel, Rodolphe ^a   Neyret, Aymeric ^a   Ekchariyawat, Peeraya ^a   Molès, Jean Pierre ^b   Simmons, Graham ^c   Chazal, Nathalie ^a   Desprès, Philippe ^d   Missé, Dorothée ^a   Briant, Laurence ^a  

^a UNIV MONTPELLIER   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d INSTITUT PASTEUR   (France)

Author keywords

Chikungunya; Innate immunity; Keratinocytes; Replication

Indexed keywords

GAMMA INTERFERON; INTERFERON; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL MEMBRANE RESISTANCE; CHEMICAL FUSION (CELL); CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INNATE IMMUNITY; KERATINOCYTE; NEWBORN; NONHUMAN; PROTEIN BINDING; RNA SYNTHESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS REPLICATION; AEDES; ANIMAL; CELL CULTURE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; VIROLOGY;

CHIKUNGUNYA VIRUS; MOSQUITO-BORNE VIRUSES;

AEDES; ANIMALS; CELLS, CULTURED; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERONS; KERATINOCYTES; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84916604104     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.11.013     Document Type: Article

References (49)

1. Angelini P., Macini P., Finarelli A.C., Pol C., Venturelli C., Bellini R., Dottori M. Chikungunya epidemic outbreak in Emilia-Romagna (Italy) during summer 2007. Parassitologia 2008, 50:97-98.
2. Bain J., Plater L., Elliott M., Shpiro N., Hastie C.J., McLauchlan H., Klevernic I., Arthur J.S., Alessi D.R., Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 2007, 408:297-315.
3. Beglin M., Melar-New M., Laimins L. Human papillomaviruses and the interferon response. J. Interf. Cytok. Res. 2009, 29:629-635.
4. Bernard E., Solignat M., Gay B., Chazal N., Higgs S., Devaux C., Briant L. Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One 2010, 5(7):e11479.
5. Bos J.D. Skin Immune System: Cutaneous Immunology and Clinical Immunodermatology 2010, CRC Press, Bocca Raton, Florida. third ed.
6. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 1988, 106:761-771.
7. Briant L., Despres P., Choumet V., Misse D. Role of skin immune cells on the host susceptibility to mosquito-borne viruses. Virology 2014, 464-465:26-32.
8. Brun S., Solignat M., Gay B., Bernard E., Chaloin L., Fenard D., Devaux C., Chazal N., Briant L. VSV-G pseudotyping rescues HIV-1CA mutations that impair core assembly or stability. Retrovirology 2008, 5(57). 10.1186/1742-4690-5-57.
9. Chang L.J., Urlacher V., Iwakuma T., Cui Y., Zucali J. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene. Ther. 1999, 6:715-728.
10. Clark K., Plater L., Peggie M., Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 2009, 284:14136-14146.
11. Couderc T., Chretien F., Schilte C., Disson O., Brigitte M., Guivel-Benhassine F., Touret Y., Barau G., Cayet N., Schuffenecker I., Despres P., Arenzana-Seisdedos F., Michault A., Albert M.L., Lecuit M. A mouse model for chikungunya: young age and inefficient Type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008, 4:e29.
12. Greiser-Wilke I., Moenning V., Kaaden O.R., Figueiredo L.T. Most alphaviruses share a conserved epitopic region on their nucleocapsid protein. J. Gen. Virol. 1989, 70:743-748.
13. Her Z., Malleret B., Chan M., Ong E.K., Wong S.C., Kwek D.J., Tolou H., Lin R.T., Tambyah P.A., Renia L., Ng L.F. Active infection of human blood monocytes by chikungunya virus triggers an innate immune response. J. Immunol. 2010, 184:5903-5913.
14. Hermant P., Michiels T. Interferon-lambda in the context of viral infections: production, response and therapeutic implications. J. Innate Immun. 2014, 6:563-574.
15. Ikeda Y., Takeuchi Y., Martin F., Cosset F.L., Mitrophanous K., Collins M. Continuous high-titer HIV-1 vector production. Nat. Biotechnol. 2003, 21:569-572.
16. Jensen S., Thomsen A.R. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J. Virol. 2012, 86:2900-2910.
17. Kummerer B.M., Grywna K., Glasker S., Wieseler J., Drosten C. Construction of an infectious chikungunya virus cDNA clone and stable insertion of mCherry reporter genes at two different sites. J. Gen. Virol. 2012, 93:1991-1995.
18. Labadie K., Larcher T., Joubert C., Mannioui A., Delache B., Brochard P., Guigand L., Dubreil L., Lebon P., Verrier B., de Lamballerie X., Suhrbier A., Cherel Y., Le Grand R., Roques P. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest. 2010, 120:894-906.
19. Lim P.Y., Behr M.J., Chadwick C.M., Shi P.Y., Bernard K.A. Keratinocytes are cell targets of West Nile virus in vivo. J. Virol. 2011, 85:5197-5201.
20. Limon-Flores A.Y., Perez-Tapia M., Estrada-Garcia I., Vaughan G., Escobar-Gutierrez A., Calderon-Amador J., Herrera-Rodriguez S.E., Brizuela-Garcia A., Heras-Chavarria M., Flores-Langarica A., Cedillo-Barron L., Flores-Romo L. Dengue virus inoculation to human skin explants: an effective approach to assess in situ the early infection and the effects on cutaneous dendritic cells. Int. J. Exp. Pathol. 2005, 86:323-334.
21. Luplertlop N., Surasombatpattana P., Patramool S., Dumas E., Wasinpiyamongkol L., Saune L., Hamel R., Bernard E., Sereno D., Thomas F., Piquemal D., Yssel H., Briant L., Misse D. Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following Infection with Dengue Virus. PLoS Pathog. 2011, 7:e1001252.
22. Mogensen K.E., Pyhala L., Cantell K. Raising antibodies to human leukocyte interferon. Acta pathologica et microbiologica scandinavica. Section B Microbiol. 1975, 83:443-450.
23. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
24. Nestle F.O., Di Meglio P., Qin J.Z., Nickoloff B.J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 2009, 9:679-691.
25. Odendall C., Dixit E., Stavru F., Bierne H., Franz K.M., Durbin A.F., Boulant S., Gehrke L., Cossart P., Kagan J.C. Diverse intracellular pathogens activate type III interferon expression from peroxisomes. Nat. immunol. 2014, 15:717-726.
26. Olagnier D., Scholte F.E., Chiang C., Albulescu I.C., Nichols C., He Z., Lin R., Snijder E.J., van Hemert M.J., Hiscott J. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J. Virol. 2014, 88:4180-4194.
27. Osterlund P.I., Pietila T.E., Veckman V., Kotenko S.V., Julkunen I. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. immunol. 2007, 179:3434-3442.
28. Ozden S., Huerre M., Riviere J.P., Coffey L.L., Afonso P.V., Mouly V., de Monredon J., Roger J.C., El Amrani M., Yvin J.L., Jaffar M.C., Frenkiel M.P., Sourisseau M., Schwartz O., Butler-Browne G., Despres P., Gessain A., Ceccaldi P.E. Human muscle satellite cells as targets of chikungunya virus infection. PLoS ONE 2007, 2:e527.
29. Rudd P.A., Wilson J., Gardner J., Larcher T., Babarit C., Le T.T., Anraku I., Kumagai Y., Loo Y.M., Gale M., Akira S., Khromykh A.A., Suhrbier A. Interferon response factors 3 and 7 protect against chikungunya virus hemorrhagic fever and shock. J. Virol. 2012, 86:9888-9898.
30. Rulli N.E., Melton J., Wilmes A., Ewart G., Mahalingam S. The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus. Ann. NY. Acad. Sci. 2007, 1102:96-108.
31. Salazar M.I., Richardson J.H., Sanchez-Vargas I., Olson K.E., Beaty B.J. Dengue virus type 2: replication and tropisms in orally infected Aedes aegypti mosquitoes. BMC Microbiol. 2007, 7:9.
32. Salvador B., Zhou Y., Michault A., Muench M.O., Simmons G. Characterization of chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 2009, 393:33-41.
33. Schilte C., Couderc T., Chretien F., Sourisseau M., Gangneux N., Guivel-Benhassine F., Kraxner A., Tschopp J., Higgs S., Michault A., Arenzana-Seisdedos F., Colonna M., Peduto L., Schwartz O., Lecuit M., Albert M.L. Type I IFN controls chikungunya virus via its action on nonhematopoietic cells. J. Exp. Med. 2010, 207:429-442.
34. Schwartz O., Albert M.L. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 2010, 8:491-500.
35. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300:1148-1151.
36. Solignat M., Gay B., Higgs S., Briant L., Devaux C. Replication cycle of chikungunya: a re-emerging arbovirus. Virology 2009, 393:183-197.
37. Sourisseau M., Schilte C., Casartelli N., Trouillet C., Guivel-Benhassine F., Rudnicka D., Sol-Foulon N., Le Roux K., Prevost M.C., Fsihi H., Frenkiel M.P., Blanchet F., Afonso P.V., Ceccaldi P.E., Ozden S., Gessain A., Schuffenecker I., Verhasselt B., Zamborlini A., Saib A., Rey F.A., Arenzana-Seisdedos F., Despres P., Michault A., Albert M.L., Schwartz O. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007, 3:e89.
38. Surasombatpattana P., Hamel R., Patramool S., Luplertlop N., Thomas F., Despres P., Briant L., Yssel H., Misse D. Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect. Genet. Evol. 2011, 11:1664-1673.
39. Thangamani S., Higgs S., Ziegler S., Vanlandingham D., Tesh R., Wikel S. Host immune response to mosquito-transmitted chikungunya virus differs from that elicited by needle inoculated virus. PLoS ONE 2010, 5:e12137.
40. Thon-Hon V.G., Denizot M., Li-Pat-Yuen G., Giry C., Jaffar-Bandjee M.C., Gasque P. Deciphering the differential response of two human fibroblast cell lines following chikungunya virus infection. Virol. J. 2012, 9:213.
41. Tsetsarkin K., Higgs S., McGee C.E., De Lamballerie X., Charrel R.N., Vanlandingham D.L. Infectious clones of chikungunya virus (La Reunion isolate) for vector competence studies. Vector Borne Zoonotic Dis. 2006, 6:325-337.
42. Van Bortel W., Dorleans F., Rosine J., Blateau A., Rousset D., Matheus S., Leparc-Goffart I., Flusin O., Prat C., Cesaire R., Najioullah F., Ardillon V., Balleydier E., Carvalho L., Lemaitre A., Noel H., Servas V., Six C., Zurbaran M., Leon L., Guinard A., van den Kerkhof J., Henry M., Fanoy E., Braks M., Reimerink J., Swaan C., Georges R., Brooks L., Freedman J., Sudre B., Zeller H. Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill. 2014, 19(13):20759.
43. Vanlandingham D.L., Tsetsarkin K., Hong C., Klingler K., McElroy K.L., Lehane M.J., Higgs S. Development and characterization of a double subgenomic chikungunya virus infectious clone to express heterologous genes in Aedes aegypti mosquitoes. Insect. Biochem. Molec. 2005, 35:1162-1170.
44. Vazeille M., Jeannin C., Martin E., Schaffner F., Failloux A.B. Chikungunya: a risk for Mediterranean countries?. Acta Trop. 2008, 105:200-202.
45. Vazeille M., Mousson L., Martin E., Failloux A.B. Orally co-Infected Aedes albopictus from La Reunion Island, Indian Ocean, can deliver both dengue and chikungunya infectious viral particles in their saliva. PLoS Negl. Trop. Dis. 2010, 4:e706.
46. Wauquier N., Becquart P., Nkoghe D., Padilla C., Ndjoyi-Mbiguino A., Leroy E.M. The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation. J. Infect. Dis. 2011, 204:115-123.
47. Wikan N., Sakoonwatanyoo P., Ubol S., Yoksan S., Smith D.R. Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage. PLoS ONE 2012, 7:e31102.
48. Witte K., Gruetz G., Volk H.D., Looman A.C., Asadullah K., Sterry W., Sabat R., Wolk K. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes immun. 2009, 10:702-714.
49. Ziegler S.A., Nuckols J., McGee C.E., Huang Y.J., Vanlandingham D.L., Tesh R.B., Higgs S. In vivo imaging of chikungunya virus in mice and Aedes mosquitoes using a Renilla luciferase clone. Vector Borne Zoonotic Dis. 2011, 11:1471-1477.